Feeds:
Posts
Comments

Archive for the ‘Conference Coverage with Social Media’ Category


DISCOVER BRIGHAM | NOVEMBER 7, 2019, 10AM – 6PM

#DISCOVERBRIGHAM

@pharma_BI

@AVIVA1950

 Aviva Lev-Ari, PhD, RN will be attending and will cover presentations in real time

ABOUT BRIGHAM RESEARCH

Discover Brigham is hosted by the Brigham Research Institute (BRI), under the umbrella of Brigham Health. Launched in 2005, the BRI’s mission is to accelerate discoveries that improve human health by bridging the gaps between science, communication and funding. The BRI’s resources help to foster groundbreaking interdepartmental and interdisciplinary research. They provide a voice for the research community and raise the profile of Brigham Research.

Speakers

http://www.discoverbrigham.org/speakers/

 

AGENDA

http://www.discoverbrigham.org/agenda/

ASK A QUESTION WITH SLI.DO!

DO YOU WANT TO SUBMIT A QUESTION TO A SPEAKER OF A SESSION? YOU CAN DO IT THROUGH SLI.DO!

2. ENTER THE EVENT CODE: DB19. THEN HIT JOIN!
3. PICK THE SESSION YOU WANT TO ASK A QUESTION. THEN ASK YOUR QUESTION!
4. YOUR QUESTION WILL BE REVIEWED AND MAY BE FORWARDED TO THE CHAIR TO ASK THE SPEAKER(S).

IT WORKS ON ANY DEVICE, YOU DO NOT NEED TO INSTALL ANYTHING!

 

Registration will open at 9:00 AM and will be located throughout the hospital including

  • Schlager Atrium (formerly known as Cabot Atrium, 45 Francis Street Lobby),
  • Schuster Lobby (75 Francis Street Entrance),
  • Shapiro Cardiovascular Center (70 Francis Street Entrance), and the
  • Hale Building for Transformative Medicine (HBTM) 1st Floor (60 Fenwood Road).

 

Click here for directions to these locations.  

NAVIGATING THE BRIGHAM IS EASIER THAN EVER

Need directions to a clinic, conference room, public space, or help assisting someone who looks lost?

Try our browser-based wayfinding tool and mobile app, BWH Maps,
which provides real-time location tracking and directions in the hospital.

Look for BWH Maps on the Apple App Store and Google Play Store,
or visit maps.brighamandwomens.org.

REGISTRATION LOCATIONS

Please visit one of the registration desks listed below to check-in, receive your badge, and collect any necessary materials. Registration will begin starting at 9:00 AM at each of the locations below.

 

Click on each location below for directions. 

  • SCHLAGER ATRIUM, FORMERLY KNOWN AS CABOT ATRIUM (45 FRANCIS ST. LOBBY)
  • SCHUSTER LOBBY (75 FRANCIS ST. LOBBY)
  • CARL J. AND RUTH SHAPIRO
    CARDIOVASCULAR CENTER
  • HALE BUILDING FOR
    TRANSFORMATIVE MEDICINE

SESSION LOCATIONS

Below you will find directions to each of the session locations.

MARSHALL A. WOLF CONFERENCE ROOM

HALE BUILDING FOR TRANSFORMATIVE MEDICINE

SESSION ROOM

FROM 60 FENWOOD ROAD:
Enter at 60 Fenwood Rd lobby entrance.

STAIRS:
Take the lobby staircase to the 2nd floor. Walk past the balcony overlooking the atrium and take the stairs on the left (Stair 2) to the 3rd floor. Once on the 3rd floor, exit the stairwell and take a right. The room is to your right through the double glass door, straight ahead.

ELEVATOR:
Take S Elevator to 3rd floor. Take a right out of the elevator. The room is past the stairwell, on your right through the double glass doors.

HALE VTC 02006B CONFERENCE ROOM

HALE BUILDING FOR TRANSFORMATIVE MEDICINE

OVERFLOW ROOM FOR MARSHALL A. WOLF CONFERENCE ROOM

FROM 60 FENWOOD ROAD:
Enter at 60 Fenwood Rd lobby entrance.

STAIRS:
Take the lobby staircase to the 2nd floor. The conference room will be on your right near the display monitor.

ELEVATOR:
Enter at 60 Fenwood Rd main entrance and take the S Elevator to the 2nd floor. Once you exit the elevator, take a right and walk past the balcony overlooking the atrium and the conference room will be straight ahead near the display monitor.

ZINNER BREAKOUT ROOM

CARL J. AND RUTH SHAPIRO CARDIOVASCULAR CENTER

SESSION ROOM

FROM 70 FRANCIS STREET:
The Zinner Breakout Room is located in the Carl J. and Ruth Shapiro Cardiovascular Center at 70 Francis Street, Boston, MA. Upon entering the building at the street level, walk straight towards the escalators in the rear of the building. The Zinner Conference Center is located on your right; the Breakout room is through the large doors on the left.

ZINNER BOARDROOM

CARL J. AND RUTH SHAPIRO CARDIOVASCULAR CENTER

OVERFLOW ROOM FOR ZINNER BREAKOUT ROOM

FROM 70 FRANCIS STREET:
The Zinner Boardroom is located in the Carl J. and Ruth Shapiro Cardiovascular Center at 70 Francis Street, Boston, MA. Upon entering the building at the street level, walk straight towards the escalator, keeping to the left side of the building. The Conference Center is located on your right; the Boardroom is through the large doors on the back wall.

BORNSTEIN FAMILY AMPHITHEATER

MAIN PIKE, 45 FRANCIS STREET LOBBY

SESSION ROOM

FROM 45 FRANCIS STREET:
Coming from 45 Francis Street lobby, walk towards the Main Pike (2nd floor hallway). Then take left on the Main Pike, 2nd door on right.

AGENDA

10:00 AM – 11:00 AM

Opening remarks

Elizabeth G. Nabel, MD, President Brigham Health, Prof. Medicine @HarvardMed

  • 8th event since 2012
  • show casing amazing research
  • Open to the Public: Patients, Families to educate
  • 90 Posters
  • Health equity perspective as DNA of the Brigham
  • Learn a new idea, meet someone new, create a new idea

Keynote Introduction

David Bates, MD @DBatesSafety

KEYNOTE

KYU RHEE, MD, MPP, VICE PRESIDENT & CHIEF HEALTH OFFICER, IBM CORPORATION & IBM WATSON HEALTH

MAIN PIKE, 45 FRANCIS STREET LOBBY
  • Partnership BWH & IBM WATSON
  • Big data of claims from providers to payers
  • Waiting rookms in Healthcare delivery
  • Government: ACA
  • AI Spring is here, no more Winter for AI
  • Health disparities, salaries, sexual orientation – improving health of populations
  • Science & Security
  • Red Hat – data security – big data statoscope
  • Healthcare Culture & Technology Culture: IBM & Amazon hire healthcare professionals
  • Cost: Burnout, managing population health,
  • Reduce physicians burnout
  • Culture Tech – Competition by IBM’s Project Debater

11:15 AM – 12:50 PM

1:00 – 1:50 PM

FROM 70 FRANCIS STREET:
The Zinner Breakout Room is located in the Carl J. and Ruth Shapiro Cardiovascular Center at 70 Francis Street, Boston, MA. Upon entering the building at the street level, walk straight towards the escalators in the rear of the building. The Zinner Conference Center is located on your right; the Breakout room is through the large doors on the left.

Aaron Goldman
HaeLin Jang
Greog K. Gerber
  • Microbiome – Bacteria and Fungus therapies – computational tools for applications on microbiome
  • Diagnostics
  • Microbiome in early childhood
  • temporal variability during adulthood
  • host disease bacteriptherapeutics: C-Diff
  • Bugs as drugs
  • Gnotobiotic mice model for c-Diff in mice
  • MDSINE – Microbial dynamin model interaction model
  • cancer microbiome: Bacteria causing cancer, cancer changing the bacteria environment

 

Jeff Karp BENG PhD @MrJeffKarp

  • tissue based patch to seal open foramane ovale. Project remained in Academic settings however
  • GLUE component was commercialized
  • bioinspiration from living organs in Nature, slugs
  1. Viscose secretions
  2. Hydrophobic secretions and snails and sand castle worms

1:00 – 1:50 PM

Lina Matta, PharmD
Joji Suzuki, MD
Lisa WIchmann
Kevin Elias, MD
Daiva Braunfelds,MBA HPH
Elizabeth Cullen, MS

2:00 – 2:50 PM

3:00 – 3:50 PM

David Levin
Christopher baugh
Kathryn Britton
Joanne Feinberg Goldstein
Amrita Shahani
If patient meets criteria for Home Hospital : all services are sent home.
2016 – Pilot randomized controlled trial
2017-2018 – Repeat of Pilot on larger population
2018 – High-volume single arm innovation services
2019 – studies within home hospital wtth sensors at home
2020 – continue
Operation and Research lead to innovations

Anna Krichevsky, PhD HMS Initiative for RNA Medicine

  • paradox of organismal complexity and # protein encoding genes
  • Human genome, 70% Transcriptome Non-coding RNA only 2% encode proteins
  • Non-coding RNA small, long, multifunctional
  • biogenesis of offending RNAs can be drugged
  • RNA novel therapies: RNA as a Drug,
  • Indications: Brain Tumors and AD: MicroRNA (miRNA)the smallest Glioblastoma – only 4 drugs FDA approved in 25 years miRNA – 10b inhibition kills gliomacells miR-132 most neuroprotective RNA
  • Cardiovascular

Paul Anderson, MD, PhD

  • ALS and FTD – Fronto Temporal Dimensia
  • Riluzone 1970 – anti Anti-glutamateric
  • Edarabone 2017 drugs approved – anti-oxidative
  • Andogenesis role in Motor protection from Stress Cytoplasmatic tRNA – ANdiogenin (ANG) production
  • 20 amino acids
  • 5″-tiRNAs assemble G-quadruples – G4
  • point mutationin ANG (mANG) reduce its RNanase
  • G4-containing DNA analogs of 5″-tiRNA (Ala)

Marc Feinberg, MD

  • Cardiovascular: CAD, Insulin resistence – Vascular inflammation
  • Impaired angiogenesis: post MI repair CHF
  • MiRNA therapeutics for Atherosclerosis – miR-181b: Aortic ECs Athero (mice) CAD (Human)
  • miRNA _ Liposomes injected in the vessel wall – reduction of inflammation in vessel – microRNA Group
  • monocyte – How can we increase or amintain mir-181b expression in endothelial cells?
  • LncRNA Therapeutics for vascular Senescence and Atherosclerosis – no effect on leucocyte accumulation no difference in inflammation
  • DNA-dependent protein kinase (DNA-PK)
  • Does Loss SNHG12 triggers vascular senescence in the vessel wall

 

Clemens Scherzer, MD

  • The Protein RNA Brain
  • Dopamin p
  • BRAINCODE: 64% RNA: mRNA, ncRNA,
  • cell-type-spacific putative enhancer RNAs (eRNAs)
  • eRNAs indicate active genetic switches
  • central dogma in Biology: DNA, non-coding RNA, Protein
  • Top 10 Markers
  • Neuropsychiatric Disease: Parkinson: How do genetic variants function in specific brain cells: neurons, microglia, astrocytes
  • genetic variants of neuropsychiatric diseases over-localize to active eRNA sites in dopamine neurons
  • enhancers RNA – ADHD,
  • enhacers RNA – schizoprania, bipolar, addiction – antopsychotic Vlporic acid
  • BRAINCODE Project: BWH MGH HMS

5:00 – 6:00 PM

AWARDS & RECEPTION

SPECIAL PHOTO-OP TO CELEBRATE YOU!
WE WILL TAKE A GROUP PHOTO DURING THE RECEPTION AND AWARDS CEREMONY TO CELEBRATE YOU, OUR INNOVATORS!
THE PHOTO WILL BE DISPLAYED AT THE BRIGHAM IN THE HALE BUILDING. WE HOPE YOU CAN JOIN US IN CELEBRATING YOUR ACHIEVEMENTS.

SOURCE

http://www.discoverbrigham.org/agenda/

Read Full Post »


@CHI 1st AI World Conference and Expo, October 23 – October 25, 2019, Seaport World Trade Center, Boston, MA.  Presentations by Four Israeli companies explaining how they use AI technologies in their products @ NEIBC Meetup AI World Conference and Expo, 10/24/2019 @6:30PM Waterfront 1

#AIWORLD

@AIWORLDEXPO

@pharma_BI

@AVIVA1950

Reporter: Aviva Lev-Ari, PhD, RN

 

  • When: October 24, 2019
  • Time: 6:30 pm
  • Where: Seaport World Trade Center, Boston, MA
  • Room Location: Waterfront 1

Speakers Includes:

Registration:

  • To gain access to NEIBC Meetup please RSVP below and use code 1968-EXHP and get complimentary pass to the exhibit
  • If you want to attend the conference, use NEIBC19 discount code and get $200 off conference registration

RSVP NOW

AI World Conference and Expo has become the industry’s largest independent business event focused on the state of the practice of AI in the enterprise. The AI World 3-day program delivers a comprehensive spectrum of content, networking, and business development opportunities, all designed to help you cut through the hype and navigate through the complex landscape of AI business solutions. Attend AI World and learn how innovators are successfully deploying AI and intelligent automation to accelerate innovation efforts, build competitive advantage, drive new business opportunities, and reduce costs.

250+ Speakers

120+ Sponsors

2700+Attendees

100+Sessions

SOURCE

From: “Dan Trajman @ NEIBC” <dan.trajman@neibc.org>

Reply-To: <dan.trajman@neibc.org>

Date: Wednesday, October 23, 2019 at 11:50 AM

To: Aviva Lev-Ari <AvivaLev-Ari@alum.berkeley.edu>

Subject: Israeli Companies Presenting at AI World October 24, 2019

 

Event Brochure

https://aiworld.com/docs/librariesprovider28/agenda/19/aiworld-conference-expo-2019.pdf

 

Plenary Program

WEDNESDAY, OCTOBER 23

9:00 AM SUMMIT KICK OFF: AI Becomes Real

Scott Lundstrom, Group Vice President and General Manager, IDC

Government and Health Insights, IDC and AI World, Conference Co-Chair

 

9:10 AM SUMMIT KEYNOTE: Business Strategy with Artificial Intelligence

Sam Ransbotham, PhD, Professor, Academic Contributing Editor,

Information Systems, Boston College; MIT Sloan Management Review

 

9:35 AM EXECUTIVE ROUNDTABLE:

AI Drives Innovation in Enterprise Applications

Moderator: Mickey North-Rizza, Research Vice President, Enterprise Applications, IDC

Panelists:

David Castillo, PhD, Managing Vice President, Machine Learning, Capital One

Mukesh Dalal, PhD, Chief Analytics Officer & Chief Data Scientist, Bose Corporation

Madhumita Bhattacharyya, Managing Director – Enterprise Data & Analytics,

Protiviti Sasha Caskey, CTO & Co-Founder, Kasisto

 

10:05 AM KEYNOTE: Evolving Role of CDAOS in the New Era – An Organizational Construct

Anju Gupta, Vice President, Chief Data and Analytics Officer, Enterprise Holdings

 

10:30 – 10:50 AM NETWORKING BREAK

 

10:50 AM EXECUTIVE ROUNDTABLE:

 

The Evolution of Conversational Assistants

 

Moderator:

Reenita Malholtra Hora, Director of Marketing & Communications, SRI International

Panelists:

William Mark, PhD, President, SRI

Karen Myers, Lab Director, SRI International’s AI Center

 

11:20 AM Talk Title to be Announced

Genevy Dimitrion VP, Enterprise Data and Analytics, Humana

 

11:40 AM How AI Maturity Impacts a Winning Corporate Strategy

Ritu Jyoti, Program Vice President, IDC

 

4:20 PM PLENARY KEYNOTE PANEL:

Learning from XPRIZE Startups to Achieve Successful AI Innovation

Moderator:

Devin Krotman, Director, IBM Watson

AI XPRIZE,

XPRIZE Foundation

 

Panelists: Eleni Miltsakaki, Founder and CEO, Choosito

Ellie Gordon, Founder, CEO, & Designer, Behaivior AI

Daniel Fortin, President, AITera Inc.

 

12:00 PM LUNCHEON KEYNOTE:

Case Studies of Conversational AI – Real Deployments at Scale

Jim Freeze, Chief Marketing Officer, Interactions

 

Sponsored by Ben Bauks, Senior Business Systems Analyst, Constant Contact

 

THURSDAY, OCTOBER 24

 

8:20 AM BREAKFAST KEYNOTE:

The Promise and Pain of Computer Vision in Retail, Healthcare, and Agriculture

Ben Schneider, Vice President, Product, Alegion

 

9:00 AM CONFERENCE INTRODUCTION

Eliot Weinman, Founder & Conference Chair, AI World; Executive Editor, AI Trends

 

9:05 AM INTRODUCTORY REMARKS

Scott Lundstrom, Group Vice President and General Manager, IDC Government and

Health Insights, IDC and AI World, Conference Co-Chair

 

9:15 AM KEYNOTE PRESENTATION:

The Human Strategy

Alex Sandy Pentland, PhD, Professor, Engineering, Business, Media Lab, MIT

 

9:45 AM KEYNOTE:

Uber’s Intelligent Insights Assistant

Franziska Bell, PhD, Director, Data Science, Data Science Platforms, Uber

 

10:15 AM KEYNOTE:

AI in Finance: Present and Future, Hype and Reality

Charles Elkan, PhD, Managing Director, Goldman Sachs

 

10:40 – 11:00 AM COFFEE BREAK

 

11:00 AM KEYNOTE:

AI at Work in Legal, News and Tax & Accounting

Khalid Al-Kofahi, PhD, Vice President, Research and Development, Head –

Center for AI and Cognitive Computing, Thomson Reuters

 

11:25AM EXECUTIVE ROUNDTABLE:

Disinformation, Infosec, Cognitive Security and Influence Manipulation

Moderator:

Michael Krigsman, Industry Analyst, CXOTalk

 

Panelist:

Sara-Jayne Terp, Data Scientist, Bodacea Light Industries LLC

Bob Gourley, Co-Founder and CTO, OODA LLC

Pablo Breuer, Director of US Special Operations Command Donovan Group and Senior Military Advisor and Innovation Officer, SOFWERX

Anthony Scriffignano, PhD, SVP, Chief Data Scientist, Dun & Bradstreet

 

Sponsored by

PUSHING THE BOUNDARIES OF AI – Providing the expertise required to accelerate the evolution of human progress in the age of artificial intelligence http://dellemc.com/AI

 

11:30 AM KEYNOTE:

How AI is Helping to Improve Canadian Lives Through AML

Vishal Gossain, Vice President, Global Risk Management, ScotiaBank

 

FRIDAY, OCTOBER 25

 

8:15 AM KEYNOTE:

AI World Society Roundtable on AI-Healthcare

Moderator:

Ed Burns, Site Editor, TechTarget

 

Panelists:

Professor David Silbersweig, Board Member of BGF, Harvard Medical

School

Professor Mai Trong Khoa, PhD, Chairman of the Nuclear Medicine and Oncology

Council, Director of the Gene-Stem cell Center, Bach Mai hospital, Senior lecturer,

Hanoi Medical University, Secrectary of the National Council of Professorship in

Medicine in Vietnam

Truong Van Phuoc, PhD, Former Acting Chairman, State Inspectory Committee

of Finance of Vietnam, Senior Advisor to Chairman, Vietbank

Truong Vinh Long, MD, CEO, Gia An 115 Hospital

 

10:00 AM KEYNOTE:

AI in Pharma: Where we are Today and How we Will Succeed in the Future

Natalija Jovanovic, PhD, Chief Digital Officer, Sanofi Pasteur

 

10:30 AM Startup Awards Announcement

John Desmond, Principal at JD Content Services, Editor AI Trends

 

10:35 – 10:50 AM COFFEE BREAK IN THE EXPO

 

10:50 AM EXECUTIVE ROUNDTABLE:

Enterprise AI Innovations

Moderator:

Nick Patience, Founder & Research Vice President, Software, 451 Research

Rudina Seseri, Founder and Managing Partner, Glasswing Venture

Norbert Monfort, Vice President, IT Transformation and Innovation, Assurant Global Technology

Dawn Fitzgerald, Director of Digital Transformation Data Center Operations, Schneider Electric

 

PLENARY PROGRAM

 

8:45 AM CONFERENCE INTRODUCTION

Scott Lundstrom, Group Vice President and General Manager, IDC Government and

Health Insights, IDC and AI World, Conference Co-Chair

 

8:50 AM KEYNOTE:

Artificial Intelligence in Sustainable Development: An Educational Perspective

Enver Yucel, Chairman, Bahçeşehir University

 

9:00 AM KEYNOTE:

Enhancing Human Capability with Intelligent Machine Teammates

Julie Shah, Associate Professor, Dept of Aeronautics and Astronautics, Computer Science and AI Lab, MIT

 

9:30 AM KEYNOTE:

Democracy, Ethics and the Rule of Law in the Age of Artificial Intelligence

Paul F. Nemitz, Principal Advisor in the Directorate-General for Justice and Consumers of the European Commission

 

12:00 PM LUNCHEON KEYNOTE:

How AI/ML is Changing the Face of Enterprise IT

Robert Ames, Senior Director, National Technology Strategy,

VMware Research, VMware

 

SOURCE

https://aiworld.com/docs/librariesprovider28/agenda/19/aiworld-conference-expo-2019.pdf

Read Full Post »


Real Time Coverage @BIOConvention #BIO2019: Dealmakers’ Intentions: 2019 Market Outlook June 5 Philadelphia PA

Reporter: Stephen J Williams, PhD @StephenJWillia2

Please follow LIVE on TWITTER using the following @ handles and # hashtags:

@Handles

@pharma_BI

@AVIVA1950

@BIOConvention

# Hashtags

#BIO2019 (official meeting hashtag)

 

Read Full Post »


Human gene editing continues to hold a major fascination within a biomedical and biopharmaceutical industries. It’s extraordinary potential is now being realized but important questions as to who will be the beneficiaries of such breakthrough technologies remained to be answered. The session will discuss whether gene editing technologies can alleviate some of the most challenging unmet medical needs. We will discuss how research advances often never reach minority communities and how diverse patient populations will gain access to such breakthrough technologies. It is widely recognize that there are patient voids in the population and we will explore how community health centers might fill this void to ensure that state-of-the-art technologies can reach the forgotten patient groups . We also will touch ethical questions surrounding germline editing and how such research and development could impact the community at large.

Please follow LIVE on TWITTER using the following @ handles and # hashtags:

@Handles

@pharma_BI

@AVIVA1950

@BIOConvention

# Hashtags

#BIO2019 (official meeting hashtag)

Read Full Post »


For @AVIVA1950, Founder, LPBI Group @pharma_BI: Twitter Analytics [Engagement Rate, Link Clicks, Retweets, Likes, Replies] & Tweet Highlights [Tweets, Impressions, Profile Visits, Mentions, New Followers]

Data collection from Twitter Analytics Pages for above Twitter Account: Aviva Lev-Ari, PhD, RN

https://analytics.twitter.com/user/AVIVA1950/tweets

Definitions

An engagement rate between 0.09% and 0.33% is considered to be high, where an influencer would expect 0.9 – 3.3 reactions for every 1000 followers onTwitter. Finally, an engagement rate between 0.33% and 1% is considered to be very high, with expected reactions to be between 3.3 – 10 for every 1000 Twitter followers.

What is a Good Engagement Rate on Twitter? – Scrunch

https://www.scrunch.com/blog/what-is-a-good-engagement-rate-on-twitter

How to calculate engagement rate on Twitter?

The Tweet Engagement Rate Formula.
The Tweet Engagement Rate takes into account the Replies and Retweets of the Tweet to the total number of Followers to date. Then it´s multiplied by 100 as well to provide you with the percentage of your Fan base that´s interacting with your Tweet.

Formulas Revealed: The Facebook and Twitter Engagement Rate …

6 engagement rate calculation methods

These are the most common formulas you’ll need to calculate engagement rates on social media.

Total engagements typically represents a tally of likes, favourites, reactions, comments, shares, views, retweets, and sometimes include clicks, depending on which platform you’re using.

1. Engagement rate by reach (ERR)

This formula is the most common way to calculate engagement with content.

ERR measures the percentage of people who chose to interact with your content after seeing it.

Use the first formula for a single post, and the second one to calculate the average rate across multiple posts.

  • ERR = total engagements per post / reach per post * 100

To determine the average, add up the all the ERRs from the posts you want to average, and divide by number of posts:

  • Average ERR = Total ERR / Total posts

In other words: Post 1 (3.4%) + Post 2 (3.5%) / 2 = 3.45%

Pros: Reach can be a more accurate measurement than follower count, since not all your followers will see all your content. And non-followers may have been exposed to your posts through shares, hashtags, and other means.

Cons: Reach can fluctuate for a variety of reasons, making it a different variable to control. A very low reach can lead to a disproportionately high engagement rate, and vice versa, so be sure to keep this in mind.

2. Engagement rate by posts (ER post)

Technically, this formula measures engagements by followers on a specific post. In other words, it’s similar to ERR, except instead of reach it tells you the rate at which followers engage with your content.

Most social media influencers calculate their average engagement rate this way.

  • ER post = Total engagements on a post / Total followers *100

To calculate the average, add up all the ER posts you want to average, and divide by number of posts:

  • Average ER by post = Total ER by post / Total posts

Example: Post 1 (4.0%) + Post 2 (3.0%) / 2 = 3.5%

Pros: While ERR is a better way to gauge interactions based on how many people have seen your post, this formula replaces reach with followers, which is generally a more stable metric.

In other words, if your reach fluctuates often, use this method for a more accurate measure of post-by-post engagement.

Cons: As mentioned, while this may be a more unwavering way to track engagements on posts, it doesn’t necessarily provide the full picture since it doesn’t account for viral reach. And, as your follower count goes up, your rate of engagement could drop off a little.

Make sure to view this stat alongside follower growth analytics.

Bonus: Get a free social media report template to easily and effectively present your social media performance to key stakeholders.

Get the free template now!

3. Engagement rate by impressions (ER impressions)

Another base audience metric you could choose to measure engagements by is impressions. While reach measures how many people see your content, impressions tracks how often that content appears on a screen.

  • ER impressions = Total engagements on a post / Total impressions *100
  • Average ER impressions = Total ER impressions / Total posts

Pros: This formula can be useful if you’re running paid content and need to evaluate effectiveness based on impressions.

Cons: An engagement rate calculated with impressions as the base is bound to be lower than ERR and ER post equations. Like reach, impression figures can also be inconsistent. It may be a good idea to use this method in conjunction with reach.

Read more about the difference between reach and impressions.

4. Daily engagement rate (Daily ER)

While engagement rate by reach measures engagement against maximum exposure, it’s still good to have a sense of how often your followers are engaging with your account on a daily basis.

  • Daily ER = Total engagements in a day / Total followers *100
  • Average Daily ER = Total engagements for X days / (X days *followers) *100

Pros: This formula is a good way to gauge how often your followers interact with your account on a daily basis, rather than how they interact with a specific post. As a result, it takes engagements on new and old posts into equation.

This formula can also be tailored for specific use cases. For instance, if your brand only wants to measure daily comments, you can adjust “total engagements” accordingly.

Cons: There’s a fair amount of room for error with this method. For instance, the formula doesn’t account for the fact that the same follower may engage 10 times in a day, versus 10 followers engaging once.

Daily engagements can also vary for a number of reasons, including how many posts you share. For that reason it may be worthwhile to plot daily engagement versus number of posts.

5. Engagement rate by views (ER views)

If video is a primary vertical for your brand, you’ll likely want to know how many people choose to engage with your videos after watching them.

  • ER view = Total engagements on video post / Total video views *100
  • Average ER view = Total ER view / Total posts

Pros: If one of your video’s objectives is to generate engagement, this can be a good way to track it.

Cons: View tallies often include repeat views from a single user (non-unique views). While that viewer may watch the video multiple times, they may not necessarily engage multiple times.

6. Factored Engagement Rate

In rare cases some marketers use a “factored engagement rate.” As the name suggests, factored engagement rates add more or less weight to certain factors in the equation.

For example, a marketer may wish to place a higher value on comments versus likes, weighting each comment as two versus one. The subsequent equation would look something like this:

  • Comment-weighted ER = (Total comments x 2) + all other engagements / Reach per post *100

Obviously, this technique inflates the resulting engagement rate and can be misleading, especially since the use of factored engagement rates is not widespread. For this reason, Hootsuite does not recommend its use.

SOURCE

https://blog.hootsuite.com/calculate-engagement-rate/

How To Measure An Influencer’s Engagement Rate (A Scientific …

 

 

July 2019

Impressions, Engagement Rate, Link Clicks, Retweets, Likes, Replies

 

2019

Average Impressions per day by Month

Monthly

Average

Engagement Rate

&

Last day of the month

Monthly

Average

Link Clicks

& Last day of the month

& average link clicks per day

Monthly

Average Retweets

& Last day of the month

& average Retweets per day

Monthly

Average

Likes

& Last day of the month

& average Likes per day

Monthly

Average Replies

& Last day of the month

& average Replies per day

January 31

N = 809

2.4% / 2.2% 33 / 3 / 1 80 / 4 / 3 129 / 5 / 4

2 /1 /0

February 28

N = 825

2.1% / 11.7% 22 / 0 / 1 24 / 3 / 1 41 / 1 / 1

1 / 0 / 0

March 31

N = 759

2.5% / 0.5% 18 / 1/ 1 37 / 1/ 1 63 / 1 / 2 1 / 0 / 0

April 30

N = 2.1K

1.0% / 1.8% 21 / 1/ 1 130 / 3 / 4 201 / 3 / 7

0 / 0/ 0

May 31

N = 2.3K

1.3% / 1.2% 51 / 3 / 2 117 / 2 / 4 142 / 2 / 5

3 / 0 / 0

June 30

N = 1.9K

1.2% / 0.1% 33 / 0 / 1 124 / 1 / 4 161 / 0 / 5

1 / 0 / 0

July 31

N = 824

0.9% / 1.1% 54 / 4/ 2 42 / 6 / 1 40 / 3 / 1

3 / 0 / 0

August

N =

October

N =

November

N =

December

N =

Tweets, Impressions, Profile Visits, Mentions, New Followers

2019

Tweets Impressions Profile visits Mentions New Followers

January

25.1K 21

February

1 23.1K 62

21

March 155 23.5K 533 153

10

April

257 64.2K 690 235 14

May

281 70.4K 691 238

28

June

206

58.4K 581 170

23

July

83 25.5K 321 62

15

August

September

October

November

December

TWEET HIGHLIGHTS
TWEET HIGHLIGHTS

Top Tweet earned 2,280 impressions

as and are in unidirectional symbiosis Food affect Microbiome in turn it affects of individuals over theirs
 5  4

Top Follower followed by 289K people

@tveitdal FOLLOWS YOU

Tweeting Climate Change news. Climate lecturer: science, policy, solutions. Director Klima 2020, former UN Director. For contact use svein@klima2020.no

Top mention earned 21 engagements

eProceeding 2019 Koch Institute Symposium – 18th Annual Cancer Research Symposium – Machine Learning and Cancer, June 14, 2019, 8:00 AM-5:00 PMET MIT Kresge Auditorium, Cambridge, MA via
 1  1
JUN 2019 SUMMARY

Tweets

206

Tweet impressions

58.4K

Profile visits

581

Mentions

170

New followers

23
TWEET HIGHLIGHTS

Top Tweet earned 3,800 impressions

create application for robots, we picked pruned by hand in high school as Summer job.
 6  5

Top Follower followed by 202K people

@Alex_Verbeek FOLLOWS YOU

Public Speaker | Moderator | Diplomat | Photographer | Yale World Fellow | Climate Change | Wildlife | Environment | Art | Energy-Water-Food | Sustainability 🌱

Top mention earned 36 engagements

 6  10

Top media Tweet earned 1,319 impressions

Dr. Maus ⁩ monitoring data from clinical trial is very important development of new targets multiple drugs multiple mechanism multiple specificities more modification to one cell contamination results
 3  3
MAY 2019 SUMMARY

Tweets

281

Tweet impressions

70.4K

Profile visits

691

Mentions

238

New followers

28
TWEET HIGHLIGHTS

Top Tweet earned 2,758 impressions

The premise of applied to 30 babies in 1st week of life new to intervention to cause desirable # molecular changes by search immunology search
 7  12

Top media Tweet earned 1,652 impressions

Amazing Disruptive Dozen Technologies ⁩ ⁦ Third Annette Kim streamlining Diagnosis Second Thomas McCoy prediction of Suicide risk FIRST Alexandra Golby Neurosurgery Imaging AI based system real time dynamic data intraop
 1  1
APR 2019 SUMMARY

Tweets

257

Tweet impressions

64.2K

Profile visits

690

Mentions

235

New followers

14
TWEET HIGHLIGHTS

Top Follower followed by 450K people

@CMichaelGibson FOLLOWS YOU

Non-Profit Founder/Leader | ❤️ Doc | Artist | Scientist | Educator | Med News Anchor https://t.co/LDrNxgwhA4 | RT ≠ endorse | Disclaimer here: https://t.co/2jtJQZQU0H

Top mention earned 8 engagements

impact of , how to maintain Boston as Biotech HUB? with ⁦⁩ attract great talent ⁦⁦⁩ culture is asset on the balance sheet PARKING
 1  2

Top media Tweet earned 440 impressions

MAR 2019 SUMMARY

Tweets

155

Tweet impressions

23.5K

Profile visits

533

Mentions

153

New followers

10
TWEET HIGHLIGHTS

Top Tweet earned 795 impressions

Top Follower followed by 252K people

@ArtistsandMusic FOLLOWS YOU

Music Lovers Network . ♫♫ Connecting  talented  with , A&Rs and Fans.   

Top mention earned 6 engagements

Top media Tweet earned 55 impressions

My week on Twitter 🎉: 34 Mentions, 10.6K Mention Reach, 18 Likes, 7 Retweets, 6.7K Retweet Reach. See yours with
 1
FEB 2019 SUMMARY

Tweets

1

Tweet impressions

23.1K

Profile visits

62

New followers

21
TWEET HIGHLIGHTS

Top Follower followed by 450K people

@CMichaelGibson FOLLOWS YOU

Non-Profit Founder/Leader | ❤️ Doc | Artist | Scientist | Educator | Med News Anchor https://t.co/LDrNxgwhA4 | RT ≠ endorse | Disclaimer here: https://t.co/2jtJQZQU0H

JAN 2019 SUMMARY

Tweet impressions

25.1K

New followers

21

Read Full Post »


MinneBOS 2019, Field Guide to Data Science & Emerging Tech in the Boston Community

August 22, 2019, 8AM to 5PM at Boston University Questrom School of Business, 595 Commonwealth Avenue, Boston, MA

 

 

MinneBOS – Boston’s Field Guide to Data Science & Emerging Tech

Announcement

Leaders in Pharmaceutical Business Intelligence (LPBI) Group

 

REAL TIME Press Coverage for

 http://pharmaceuticalintelligence.com 

by

 Aviva Lev-Ari, PhD, RN

Director & Founder, Leaders in Pharmaceutical Business Intelligence (LPBI) Group, Boston

Editor-in-Chief, Open Access Online Scientific Journal, http://pharmaceuticalintelligence.com

Editor-in-Chief, BioMed e-Series, 16 Volumes in Medicine, https://pharmaceuticalintelligence.com/biomed-e-books/

@pharma_BI

@AVIVA1950

#MinneBos

 

Logo, Leaders in Pharmaceutical Business Intelligence (LPBI) Group, Boston

Our BioMed e-series

WE ARE ON AMAZON.COM

 

https://lnkd.in/ekWGNqA

 

UPDATED AGENDA

Thursday, August 22 • 9:30am – 10:15am
Histopathological images are the gold standard tool for cancer diagnosis, whose interpretation requires manual inspection by expert pathologists. This process is time-consuming for the patients and subject to human error. Recent advances in deep learning models, particularly convolutional neural networks, combined with big databases of patient histopathology images will pave the path for cancer researchers to create more accurate guiding tools for pathologists. In this talk, I will review the latest advances of big data in healthcare analytics and focus on deep learning applications in cancer research. Targeted at a general audience, I will provide a high-level overview of technical concepts in deep learning image analysis, and describe a typical cloud-based workflow for tackling such big data problems. I will conclude my talk by sharing some of our most recent results based on a wide range of cancer types.

Speakers

avatar for Mohammad Soltanieh-ha, PhD

Mohammad Soltanieh-ha, PhD

Clinical Assistant Professor, Boston University – Questrom
Mohammad is a faculty at Boston University, Questrom School of Business, where he teaches data analytics and big data to master’s students. Mohammad’s current research area involves deep learning and its applications in cancer research.

10:15am

10:30am

Thursday, August 22 • 10:30am – 11:00am

Deep learning image recognition and classification models for fashion items

Large scale image recognition and classification is an interesting and challenging problem. This case study uses fashion-MNIST dataset that involves 60000 training images and 10000 testing images. Several popular deep learning models are explored in this study to arrive at a suitable model with high accuracy. Although convolutional neural networks have emerged as a gold-standard for image recognition and classification problems due to speed and accuracy advantages, arriving at an optimal model and making several choices at the time of specifying model architecture, is still a challenging task. This case study provides the best practices and interesting insights.

Speakers

avatar for Bharatendra Rai

Bharatendra Rai

Professor, UMass Dartmouth
Bharatendra Rai, Ph.D. is Professor of Business Analytics in the Charlton College of Business at UMass Dartmouth. His research interests include machine learning & deep learning applications.
  • Train data: 60,000
  • Test data: 10,000
  • Dataset available from Google MNIST Fashion Data – items in DB: data already labelled
  • Label and Description
  • Architecture: Input >> Conv >> Conv >> Pooling >> Dropout << Dense <<Flatten << Dropout >> Output
  • CNN vs Fully connected: 320 parameters: 3x3x1x32 + [32 BIAS TERM] = 320 vs
  • fully connected network parameters is 16 million
  • Train the model: 15 iterations – Training and Validation
  • Actual vs Predicted: 94% was classified correctly = Accuracy: 94% 5974 vs 4700 (78%)
  • Confusion Matrix – Test 720 correctly classified for item 6  – Probability va Actual Vs Predicted
  • Image generation: Noise . gnerator Network > fake Image vs Real image – GAN Loss va Discriminator Loss
  • CNN network help reduce # of parameter
  • Droppot layers can help reduce overfitting
  • validation split of x%chooses last x% of train data
  • Generation of new data is challenging

11:00am

11:15am

Thursday, August 22 • 11:15am – 12:00pm

Rapid Data Science

Most companies today require fast, traceable, and actionable answers to their data questions. This talk will present the structure of the data science process along with cutting edge developments in computing and data science technology (DST) with direct applications to real world problems (with a lot of pictures!). Everything from modeling to team building will be discussed, with clear business applications.

Speakers

avatar for Erez Kaminski

Erez Kaminski

Leaders Global Operations Fellow, MIT
Erez has spent his career helping companies solve problems using data science. He is currently a graduate student in computer science and business at MIT. Previously, he worked in data science at Amgen Inc. and as a technologist at Wolfram Research.

12:00pm

1:00pm

Thursday, August 22 • 1:00pm – 1:45pm

Health and Healthcare Data Visualization – See how you’re doing

Health and healthcare organizations are swimming in data but few have the skills to show and see the story in their data using the best practices of data visualization. This presentation raises awareness about the research that inform these best practice and stories from the front of groups who are embracing them and re-imagining how they display their data and information. These groups include the NYC Dept of Health & Mental Hygiene, The Centers for Medicare and Medicaid (CMS), and leading medical centers and providers across the country.

Speakers

avatar for Katherine Rowell

Katherine Rowell

Co-Founder & Principal, Health Data Viz
Katherine Rowell is a health, healthcare, and data visualization expert. She is Co-founder and Principal of HealthDataViz, a Boston firm that specializes in helping healthcare organizations organize, design and present visual displays of data to inform their decisions and stimulate… Read More →
  • dashboard for Hospital CEOs

1:45pm

2:00pm

Thursday, August 22 • 2:00pm – 2:45pm

AI in Healthcare

Benefits, challenges and impact of AI and Cybersecurity on medicine.

Speakers

avatar for Vinit Nijhawan

Vinit Nijhawan

Lecturer, Boston University
Vinit Nijhawan is an Entrepreneur, Academic, and Board Member with a track record of success, including 4 startups in 20 years.
  • US: Spends the most on Health Care (HC) death per 100K people is the highest
  • Eric Topol – Diagnosis is not done correctly, AI will help with diagnosis
  • Diagnosis — AI will have the most impact; VIRAL infections are diagnosed as bacterial infections and get antibiotics for treatment
  • Image Classification my ML – decline below to human misclassification
  • Training Data sets – Big data
  • Algorithms getting better
  • Data Capture getting better – HC as well
  • Investment in HC is the greatest
  • SECURITY related to Implentable Medical Devices = security attacks – hacking and sending signal to implentable devices

2:45pm

3:00pm

Empower

Thursday, August 22 • 3:00pm – 3:30pm

Patient centric AI: Saving lives with ML driven hospital interventions

This presentation will cover the use of machine learning for maximizing the impact of a hospital readmissions intervention program. With machine learning, clinical care teams can identify and focus their intervention efforts on patients with the highest risk of readmission. The talk will go over the goals, logistics, and considerations for defining, implementing, and measuring our ML driven intervention program. While covering some technical details, this presentation will focus on the business implementation of advanced technology for helping people live healthier lives.

Speakers

avatar for Miguel Martinez

Miguel Martinez

Data Scientist, Optum
Miguel Martinez is a Data Scientist at Optum Enterprise Analytics. Relied on as a tech lead in advancing AI healthcare initiatives, he is passionate about identifying and developing data science solutions for the benefit of organizations and people.

 

3:30pm

3:45pm

Thursday, August 22 • 3:45pm – 4:15pm

Using Ontologies to Power AI Systems

There’s a great deal of confusion about the role of a knowledge architecture in artificial intelligence projects. Some people don’t believe that any reference data is necessary. But in reality reference data is required- even if there is no metadata or architecture definitions outside defined externally for an AI algorithm, someone has made the decisions about architecture and classification within the program. However, this will not work for every organization because there are terms, workflows, product attributes, and organizing principles that are unique to the organization and that need to be defined for AI tools to work most effectively.

Speakers

avatar for Seth Earley

Seth Earley

CEO, Earley Information Science
Seth Earley is a published author and public speaker about artificial intelligence and information architecture. He wrote “There’s no AI without IA” which has become an industry catchphrase used by a number of people including Ginny Rometty, the CEO of IBM.
  • Ontology, taxonomies, thesauri – conceptual relationships
  • Object-Oriented Programming and Information Architecture using AI is Old wine in new bottles

4:15pm

Thursday, August 22

TBA

 Senior Leadership Panel: Future Directions of Analytics

This panel includes senior leaders from across industry, academia & government to discuss challenges they are tackling, needs they anticipate and goals they will achieve

Moderators

avatar for Bonnie Holub, PhD

Bonnie Holub, PhD

Industry & Business Data Science, Teradata
Bonnie has a PhD in Artificial Intelligence and specializes in correlating disparate sets of Big Data for actionable results.

Read Full Post »


Leaders in Pharmaceutical Business Intelligence (LPBI) Group

 

is pleased to announce its sponsorship and invite you to attend

The New England Venture Summit presented by youngStartup Ventures.

Special discount offered   

Use discount code LPBI-VIP and receive 10% off the “early bird” rates.

 

Call for Top Innovators to present to leading Investors (details below).

 

New England Venture Summit

December 3rd & 4th 2019 | Hilton | Boston, Dedham

Where Innovation Meets Capital

 

 http://bit.ly/2M8rxzd

UPDATES

From: “Gil Garalnick [FinTrack Venture Summit]” <Gil@youngstartup.com>

Date: Monday, October 7, 2019 at 3:45 PM

To: Aviva Lev-Ari <AvivaLev-Ari@alum.berkeley.edu>

Subject: RE: Industry Partnership Update: New England Venture Summit

 

Hi Aviva –

 

Pleased to share an updated list of over 100 VCs and Angels confirmed to speak.

 

Early bird rates end October 31st. Would it feasible to share an update with your network? I can send over updated copy.

 

Partial List of over 100 VCs & Angel Investors confirmed to speak and judge includes:

Anil Achyuta, Investment Director, TDK Ventures | Omair Ahmed, Associate, Echo Health Ventures | Mark Austin, Managing Director, Viridian Capital | Natalie Bartlett, Investor, General Catalyst | Ned Berman, Senior Associate, Samsung Catalyst Fund | Carsten Boers, Managing Partner, Rhapsody Venture Partners | Greg Bohlen, Managing Director, Union Grove Venture Partners | Caitlin Bolnick, Investor, OpenView Venture Partners | Eric Breese, Investment Manager, Evonik Venture Capital | Brendan Brits, Investor, Bertelsmann Digital Media Investments | Ciara Burnham, Partner, QED Investors | Daniel Burstein, Managing Partner, Millennium Technology Value Partners | Jeffrey Carter, General Partner, West Loop Ventures | Kathryn Cartini, Partner, Chloe Capital | Anup Chamrajnagar, Investor, Point72 Ventures | Sean Cheng, Investment Manager, Philips Ventures | Elizabeth Cho-Fertikh, Co-Founder & Managing Director, MEDA Angels | Andrew Clapp, Managing Director, CIG CAP | Iain Cooper, Manager Corporate Ventures, Schlumberger Technology Investments | Mark Cupta, Partner, Prelude Ventures | Kapil Desai, Vice President, Catalyst Investors | Damien Despinoy, Director, Energy Foundry | Dan Doble, Managing Director, SABIC Ventures | Jesse Draper, Founding Partner, Halogen Ventures | Tyler Durham, Principal, Schlumberger Technology Investments | Laura Easton, Analyst, Real Ventures | Jonathan Friedlander, Principal, Digitalis Ventures | Lisa Frusztajer, Lead Investor, Portfolia Enterprise Fund | Stan Fung, Managing Director, FarSight Ventures | Robert Garber, Partner, 7wire Ventures | Stephen Gilfus, Founder, Blackboard Inc. | Emilia Gonzalez, Principal, Joyance Ventures | Ajay Gopal, Founding Principal, Framework Venture Partners | Michelle Gouveia, Associate, Sandbox Insurtech Ventures | Edward Greer, Corporate Technology Scout, Dow Ventures | Vicky Guo, Investment Director, Pearson Ventures | Brooke Hammer, Associate, F-Prime Capital | Jana Hanova, Director, Evok Innovations | Andrew Hartford, Managing Partner, Hartford Lab | Martin Heidecker, Director, Investment Manager, Boehringer Ingelheim Venture Fund | Kaitlyn Henry, Associate, OpenView Venture Partners | Jay Karandikar, Venture Partner, New Crop Capital | Madeline Keulen, Vice President, Victress Capital | Roman Kikta, Managing Partner & Founder, Mobility Ventures | Frank Klemens, Managing Director, DuPont Ventures | Diana Kontsevaia, Investor, Dell Technologies Capital | Ventures | Luda Kopeikina, Investment Director, DSM Venturing | Elaine Kunda, Founder & Managing Director, Disruption Ventures | Logan Langberg, Principal, Imaginary Ventures | James Lee, Investment Associate Director, Photon Fund | Claire Leurent, Managing Director, Samsung Ventures | Darwin Ling, Founding General Partner, Good AI Capital | Jim Lockheed, Investment Associate, JetBlue Technology Ventures | Mary Long-Irwin, Executive Director, Northern Ontario Angels | Wasim Malik, Managing Partner, Iaso Ventures | Hollis McGuire, Director, Impact NH Fund | Sarah Millar, Associate, City Light Capital | Craig Mullett, Director, Angel Investor Forum | Jared Newman, Associate, Betawork Ventures | Clay Norris, Investment Associate, Carolinas Fintech Ventures | Mike Perry, Investment Associate, Link Ventures | Lauren Michelle Pfeifer, Principal, Maschmeyer Group Ventures | Jeff Ransdell, General Partner, Rokk3r Fuel ExO | Wanda Reindorf, Managing Director, Clean Energy Venture Group | Alison Andrews Reyes, General Partner, 1843 Capital | Lisa Rhoads, Managing Director, Easton Capital Investment Group | Mark Robinson, Founder and Managing Director, WAVE Equity Partners | Gus Roman, Venture Capital Associate, Global Founders Capital | Rob Rosenberg, Partner, Prolog Ventures | Tayo Sanders, Associate, Anzu Partners | Jennifer Schretter, Partner, PROOF VC | Reese Schroeder, Managing Director, Tyson Ventures | Paul Seidler, Managing Director, Clean Energy Trust | Shantnu Sharma, Managing Director, AMD Ventures | Jean Sini, Angel Investor | Vivek Soni, Venture Partner, S Cap Cleantech Fund | Joseph Spivack, Angel Investor | Alex Steiner, Investment Analyst, Anthemis Group | Lutz Stoeber, Investment Director, Evonik Venture Capital | Neil Swami, Principal, Catalyst Health Ventures | Alexander Urban, Associate, Shell Ventures | Claude Vachet, Managing Partner, Cycle Capital Management | Erica Van, Investor, Charles River Ventures | Patrick Walsh, Director, National Grid Partners | Raymond Wang, Investor, Two Sigma Ventures | Greg Zaic, Principal and General Partner, NMT Capital | Lu Zhang, Founder & Managing Partner, Fusion Fund | Sebastian Zhou, Investor, Alpha Square Group | Chris Zock, Managing Director, Sandbox Insurtech Ventures and many more…

 

Look forward to hearing from you.

 

 

Regards

 

Gil

 

Gil Garalnick

Associate 
youngStartup Ventures
“Where Innovation Meets Capital”

 

p: 212.202.1002

e: gil@youngstartup.com

u: www.youngstartup.com

 

Friends,

 

Come meet, interact and network with hundreds of VCs, Corporate VCs, angel investors, investment bankers and founders of venture backed, emerging and early stage companies on the Lifesciences/Healthcare Track at the prestigious New England Venture Summit being held on December 3rd & 4th 2019 at the Hilton in Boston, Dedham.

 

Whether you’re a Lifescience/Healthcare startup seeking capital and exposure, or a Biotech investor seeking new deals, The New England Venture Summit presented by youngStartup Ventures – is the event of the year you won’t want to miss.

 

A highly productive venture conference, the Lifesciences/Healthcare track at The New England Venture Summit is dedicated to showcasing VCs, Corporate VCs and angel investors committed to funding venture backed, emerging and early stage companies.

 UPDATED on 8/27/2019

 

VCs & Angel Investors confirmed to speak and judge includes:

Mark Austin, Managing Director, Viridian Capital | Greg Bohlen, Managing Director, Union Grove Venture Partners | Ciara Burnham, Partner, QED Investors | Jeffrey Carter, General Partner, West Loop Ventures | Kathryn Cartini, Partner, Chloe Capital | Anup Chamrajnagar, Investor, Point72 Ventures | Andrew Clapp, Managing Director, CIG CAP | Iain Cooper, Manager Corporate Ventures, Schlumberger Technology Investments | Jesse Draper, Founding Partner, Halogen Ventures | Tyler Durham, Principal, Schlumberger Technology Investments | Robert Garber, Partner, 7wire Ventures | Stephen Gilfus, Founder, Blackboard Inc. | Emilia Gonzalez, Principal, Joyance Ventures | Ajay Gopal, Founding Principal, Framework Venture Partners | Michelle Gouveia, Associate, Sandbox Insurtech Ventures | Martin Heidecker, Director, Investment Manager, Boehringer Ingelheim Venture Fund | Kaitlyn Henry, Associate, OpenView Venture Partners | Jay Karandikar, Venture Partner, New Crop Capital | Roman Kikta, Managing Partner & Founder, Mobility Ventures | Elaine Kunda, Founder & Managing Director, Disruption Ventures | Darwin Ling, Founding General Partner, Good AI Capital | Sarah Millar, Associate, City Light Capital | Craig Mullett, Director, Angel Investor Forum | Jared Newman, Associate, Betawork Ventures | Lauren Michelle Pfeifer, Principal, Maschmeyer Group Ventures | Lisa Rhoads, Managing Director, Easton Capital Investment Group | Mark Robinson, Founder and Managing Director, WAVE Equity Partners | Tayo Sanders, Associate, Anzu Partners | Reese Schroeder, Managing Director, Tyson Ventures | Paul Seidler, Managing Director, Clean Energy Trust | Jean Sini, Angel Investor | Vivek Soni, Venture Partner, S Cap Cleantech Fund | Alex Steiner, Investment Analyst, Anthemis Group | Claude Vachet, Managing Partner, Cycle Capital Management | Erica Van, Investor, Charles River Ventures | Raymond Wang, Investor, Two Sigma Ventures | Greg Zaic, Principal and General Partner, NMT Capital | Lu Zhang, Founder & Managing Partner, Fusion Fund | Chris Zock, Managing Director, Sandbox Insurtech Ventures and many more…

 

Lineup of over 120 VCs & Angels that spoke and judged at NEVS18 includes:

Karine Agajanian, Analyst, Anzu Ventures | Sanjay Aggarwal, Venture Partner, F-Prime Capital Partners | Magdi Amin, Investment Partner, Omidyar Network | Peter Arkell, Investor, Norwest Venture Partners | Mark Austin, Partner, Bright Capital | Salman Azhar, Managing Director, Duke Angel Network | Ibraheem Badejo, Sr. Director, Johnson & Johnson Innovation | Sunny Bai, Associate, CRCM Ventures | Janet Bannister, Partner, Real Ventures | Peter Bastien, Partner, Next47 | Alex Beletsky, Investor, Sidecar Angels | Woody Benson, Venture Partner, Launch Capital | Joshua Berg, Investment Manager, GM Ventures | Raghav Bhargava, Associate, NEA | Victor Bian, Associate, Intellectual Ventures | Laura Bock, Investor, QED Investors | Nabil Borhanu, Managing Partner, Graphene Ventures | Will Borthwick, Senior Associate, Bold Capital Partners | Lee Bouyea, Managing Director, FreshTracks Capital | Eric Breese, Managing Director, Evonik Venture Capital | Maxx Bricklin, Founding Principal, Bold Capital Partners | Dan Burstein, Managing Partner, Millennium Technology Value Partners | Jason Cahill, Founder & Managing Director, McCune Capital | Neil Callahan, Co-Founder and Managing Director, Pilot Growth Equity | Efayomi Carr, Associate, Quona Capital | Sara Chamberlain, Managing Director, Energy Foundry | Raymond Chang, Managing Director, NXT Ventures | Christopher Chu, Managing Director, Samsung Catalyst Fund | Meghan Cross Breeden, Managing Partner, Red Bear Angels | David Cruikshank, Partner, ARCH Venture Partners | Sophia Dardashti, Associate, WorldQuant Ventures | Ekaterina Dorozhkina, Managing Partner, Starta Ventures | Miriam Eaves, Venture Partner, BP Ventures | Kathryn Meng Elmes, Investment Associate, Massachusetts Clean Energy Center | Alison Ernst, Senior Manager of Investments, Massachusetts Clean Energy Center | Teresa Esser, Managing Director, Silicon Pastures | Michael Fanfant, Investor, Runa Capital | David Feldman, Analyst, Indicator Ventures | Mark G. Fields, Partner, Alsop Louie Partners | Shawn Flynn, Investment Director, Bay Angels | Prashant Fonseka, Principal, Tuesday Capital | Haley Fradkin, Investment Associate, Plum Alley | Lisa Frusztajer, Investor, Portfolia Enterprise Fund | Kyle Fugere, Head of Ventures, dunnhumby Ventures | Matt Gatto, Partner, Insight Venture Partners | Joy Ghosh, Investor, Bain Capital Ventures | Stephen Gilfus, Founder, Blackboard Inc. | Jamil Goheer, Managing Partner & Cofounder, CoVenture | Ben Gorman, Associate, F-Prime Capital Partners | Edward Greer, Corporate Technology Scout, Dow Ventures | Jacob E. Grose, Investment Manager, BASF Venture Capital | Zain Gulamali, Investor, Amazon Alexa Fund | Marina Hadjipateras, Co-Founder & General Partner, Trail Mix Ventures | Hunter Hartwell, Principal, Forte Ventures | Laurence Hayward, Founding Partner, Independence Equity | Nathaniel Henshaw, Managing Director, CEI Ventures | Michael Hoeksema, Associate, Battery Ventures | Lindsay Hyde, Venture Partner, Moderne Ventures | Oren Isacoff, Principal, Longitude Capital | Nicolas Jacques-Bouchard, Principal, Panache Ventures | Jamie James, Managing Partner, GreenSoil Building Innovation Fund | Noel Jee, Investor, Illumina Ventures | Lacey Johnson, Principal, Green D Ventures | Ajay Kamat, Managing Director, Pear Ventures | Alex Kaufman, Investment Associate, JetBlue Technology Ventures | Shane Kelly, Head of Investments, CrowdSmart | Patrick Kenealy, Managing Director, Ridge Ventures | Jack Kerrigan, Managing Director, Razor’s Edge Ventures | Jonathan Kerstein, Associate, Red Sea Ventures | Nyla Koncurat, Managing Partner, Karlani Capital | Daniel Kwak, Investor, Point72 Ventures | Vivek Ladsariya, Partner, SineWave Ventures | Donna Lecky, Managing Director, Health Venture Capital | Linus Liang, Senior Associate, Signia Venture Partners | Bion Ludwig, Partner, Savano Capital Partners | Kyle Lui, Principal, DCM Ventures | Tamim Abdul Majid, Principal, OCA Ventures | Nurzhas Makishev, Managing Partner, NKM Capital | Eller Mallchok, Managing Director, Jumpstart Foundry | Coppelia Marincovic, Investment Manager, Solvay Ventures | Olga Maslikhova, Managing Partner, Phystech Ventures | Tom Mastrobuoni, Chief Financial Officer, Tyson Ventures | Hiroki Matsuda, Investor, Sozo Ventures | Derek Mazur, Senior Associate, Sante Ventures | David Miller, Co-Founder and Managing Director, Clean Energy Ventures | Julia Moore, Partner, Breakout Ventures | Kirsten Morbeck, Managing Director, SpringRock Ventures | Amit Mulgaonkar, Investor, Mithril Capital Management | Sheila Narayan, Managing Director, Golden Seeds | David Nault, General Partner, Luge Capital | Sara M. Nayeem, Partner, NEA | Brian Panoff, Senior Principal, Shell Ventures | Sumay Parikh, Principal, Quake Capital | Daniel Povitsky, Vice President, Sinai Ventures | Vinny Pujji, Investor, Insight Venture Partners | Venu Raghavan, Vice President, Wasson Enterprise | Gopal Rajaraman, Investment Principal , Motorola Solutions Venture Capital | Wanda Reindorf, Managing Director, Clean Energy Ventures | Brendan Rempel, Associate, OpenView Venture Partners | Martin Ringlein, Venture Partner, NextGen Venture Partners | Praveen Sahay, Managing Director, WAVE Equity Partners | Louis Schick, Founding Partner, NewWorld Capital Group | Chris Seitz, Associate, Excel Venture Management | Connie Sheng, Founding Managing Partner, Nautilus Venture Partners | Alex Shtarkman, Associate, Revolution | John Simon, Managing Director, Sigma Prime Ventures | Sidarth Singh, Investor, Stripes Group | Emily Snyder, Associate, Borealis Ventures | Vivek Soni, Managing Director, TiE-Boston Angels | Siri Srinivas, Associate, Draper Associates | Luisa Sucre, Associate, Revolution | Lyndsey Toeppen, Vice President, Sandbox Insurtech Ventures | Tibor Toth, Managing Director, Massachusetts Clean Energy Center | Laurel Touby, Partner, Supernode Ventures | Chisom Uche, Associate, SixThirty | Alexander Urban, Principal, Shell Ventures | Claude Vachet, Managing Partner, Cycle Capital Management | Maria Velissaris, Investor, Pipeline Angels | Anthony Walsh, Principal, BioInnovation Capital | John Wei, Sr. Investment Manager, SABIC Ventures | Jamie M. Weston, Managing Director, Spring Mountain Capital | Christopher J. Whalen, Managing Director, New Technology Ventures | Thomas Whiteaker, Partner, Propel Venture Partners | Jillian Williams, Investor, Anthemis Group | Troy Williams, Managing Director, University Ventures | Lu Zhang, Founder & Managing Partner, Fusion Fund | Sanjay Zimmermann, Associate, White Star Capital and many more.

 

Special Offer:

Leaders in Pharmaceutical Business Intelligence (LPBI) Group has made special arrangement for our network to receive a special discount of 10% off the existing “early bird” savings.

This conference will be attended by the best people in the industry. Please register early to avoid disappointment. 

 

Register Today & Save Click here.   

(Use promo code “LPBI-VIP”)

 

In addition to providing access to leading Investors, the conference will feature more than 100 pre-screened venture backed, emerging and early stage companies seeking capital, and hardcore networking. 

 

 

Call for TOP INNOVATORS!

Get Noticed > Get Funded > Grow Faster

 

A select group of more than 100 Top Innovators from the Life Sciences/Healthcare sector will be chosen to present their breakthrough investment opportunities to an exclusive audience of Venture Capitalists, Corporate Investors, Private Investors, Investment Bankers, and Strategic Partners.

 

Apply to Present / Nominate a company:

For more information or to be considered for one of the Top Innovator slots click here.

 

Seed Pitchfest:

If you are a seed stage company seeking angel funding of less than $1M (and have raised less than $300,000) click here to apply for our Seed stage track.

 

We look forward to seeing you there. 

 

Leaders in Pharmaceutical Business Intelligence (LPBI) Group

&

youngStartup Ventures

 

REAL TIME Press Coverage for

 http://pharmaceuticalintelligence.com 

by

 Aviva Lev-Ari, PhD, RN

Director & Founder, Leaders in Pharmaceutical Business Intelligence (LPBI) Group, Boston

Editor-in-Chief, Open Access Online Scientific Journal, http://pharmaceuticalintelligence.com

Editor-in-Chief, BioMed e-Series, 16 Volumes in Medicine, https://pharmaceuticalintelligence.com/biomed-e-books/

@pharma_BI

@AVIVA1950

 #NEVS

 

Logo, Leaders in Pharmaceutical Business Intelligence (LPBI) Group, Boston

Our BioMed e-series

WE ARE ON AMAZON.COM

https://lnkd.in/ekWGNqA

2019 New England Venture Summit, December 3rd & 4th 2019 at the Hilton in Boston, Dedham, MA, hosted by youngStartUp #NEVS

 

AGENDA

Wednesday, December 4th, 2019

8:00 am

CONFERENCE REGISTRATION & CONTINENTAL BREAKFAST

8:50 am

WELCOME REMARKS

9:00 am

THE CHANGING VENTURE WORLD: WHAT CAN WE EXPECT FOR THE NEXT 24 MONTHS?

Venture Capital thought leaders debate the challenges and opportunities facing Investors and Entrepreneurs

9:50 am

BREAK

10:00 am

COMPANY PRESENTATIONS – ROUND I

11:00 am

NETWORKING & REFRESHMENT BREAK

11:40 am

COMPANY PRESENTATIONS – ROUND II

12:50 pm

LUNCH & NETWORKING

1:00 pm

RAISING ANGEL MONEY – INFO & INSIGHTS FROM SEASONED INVESTORS

1:50 pm

COMPANY PRESENTATIONS – ROUND III

3:00 pm

FUNDABLE DEALS: MAKING VCs SIT UP AND TAKE NOTICE

Ideas are all well and good, but in order to attract capital they will need to be packaged and presented in a way that will entice investors and of course a SOLID business model.  This panel will discuss the skills required to make a highly effective pitch that will attract potential financiers and the types of deals investors want.

3:00 pm

ENERGIZING THE FLOW OF CLEAN-TECH DEALS

This session will discuss the trends in the financial markets and the future of venture capital investment in clean-tech.

3:00 pm

ABCs ON ED-TECH INNOVATION & FUNDING

Ed-tech Investors will take center stage to grade the Ed-tech sector and share insights on the trends they’re seeing.

3:50 pm

NETWORKING & REFRESHMENT BREAK

4:30 pm

THE ART OF NEGOTIATING TERMS SHEETS

Entrepreneurs who don’t prepare well for term-sheet negotiations may find themselves locked into an uncomfortable relationship with their VC for years to come.  Whether you’re looking for a first round or follow-up funding, attend this panel to learn what you should know about negotiating term sheets.

4:30 pm

CORPORATE VENTURE CAPITAL: WHAT YOU NEED TO KNOW

With a new flowering of startup innovation, many giants of industry have decided to enter or re-enter the world of VC. This session will explore the value-added investment approach of Corporate VCs and how it yields important dividends that are “beyond the bottom line,” both for the investor and for the startup.

5:20 pm

AWARDS & CLOSING REMARKS

5:30 pm

SUMMIT ADJOURNS

SPEAKERS

https://youngstartup.com/newengland2019/#speakers-sec

Read Full Post »

Older Posts »